Adagia Partners is announcing the acquisition of Technoflex S.A. (“Technoflex”), a global leader in high-end flexible bags for the pharmaceutical and biopharmaceutical industries, alongside certain historical investors, from Crédit Mutuel Equity.
This acquisition marks the fourth investment from Adagia Partners’ €1.3 billion investment platform. The terms of the transaction have not been disclosed.
 
Founded in 1972, Technoflex is a pioneer in the field of intravenous drug delivery bags, offering innovative solutions that meet the highest standards of safety and reliability. The company’s products include a wide range of flexible bags and connectors that are critical for the safe storage and administration of injectable drugs. Positioned in the premium segment of the market, Technoflex generates over 50% of its sales in the USA, reflecting its strong global presence and reputation.
 
Headquartered in Bidart, France, Technoflex employs 265 people.
 
For the past 50 years, Technoflex has been a trusted partner for blue-chip pharmaceutical companies, biotech firms, and CDMOs, building long-term relationships by providing solutions tailored to their needs. In recent years, Technoflex has focused on developing innovative drug delivery systems that facilitate handling by caregivers and reduce errors during the administration of injectable drugs.
 
With the support of Adagia Partners, Technoflex aims to further strengthen its strategic position as a provider of high-value, customized drug delivery solutions for complex and sensitive pharmaceuticals. The company plans to expand its international footprint and enhance its product offerings by leveraging its strong internal research and development capabilities. With this unitranche financing, CAPZA Private Debt team will support the Group in their growth journey.